Progress in treatment of multiple myelomain year 2012
Journal Title: OncoReview - Year 2013, Vol 3, Issue 2
Abstract
Authors and Affiliations
Artur Jurczyszyn, Anna Engel
Keywords
Related Articles
- EP ID EP53212
- DOI -
- Views 236
- Downloads 0
Off-label drug use in breast cancer therapy
Breast cancer is one of the most common malignancies across the world, including Poland. Chemotherapy plays an important part in the treatment of the disease. Most of the available chemotherapy drugs and regimens have un...
Why does reimbursement of orphan drugs require a specific approach?
The greatest problem concerning the reimbursement of orphan products is their high price. In the case of orphan drugs, reimbursement and pricing decisions are highly interrelated. In decisions concerning reimbursement of...
Early molecular response as a criterion of optimal response to chronic myeloid leukemia treatment with tyrosine kinase inhibitors
Maximal reduction of leukemic BCR/ABL-positive cells and achievement of persistent deep molecular response with the chance for sustained treatment-free survival in possibly all patients is a current goal of chronic myelo...
Mięsakorak trzonu macicy jako trzeci nowotwór pacjentki - opis przypadku i omówienie aktualnych zaleceń postępowania
Postęp w leczeniu systemowym przerzutowego raka nerki związany jest z rejestracją nowych leków. Przyniosło to poprawę wyników leczenia, ale zmusza również do dokonywania wyboru leku. Decyzja ta jest szczególnie istotna w...
Changes in the gastrointestinal mucosa after radio- and chemotherapy of the neoplasms
Gastrointestinal mucositis induced by radio- and chemotherapy of the neoplasms is associated with morphological changes in the mucosa of the alimentary tract. The pain, ulceration, nausea, vomiting and diarrhea are the e...